Medicare price negotiations carry on as HHS responds to Big Pharma's IRA counteroffers

Medicare drug price negotiations under the Inflation Reduction Act (IRA) are steadily progressing after drugmakers recently submitted their counteroffers to the government's initial pricing proposals.